InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,231.60
(
-0.14%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,113.10
(
-1.09%
)
Post# of 252300
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: pcrutch post# 143378

Wednesday, 06/06/2012 3:37:31 PM

Wednesday, June 06, 2012 3:37:31 PM

Post# of 252300

$100 million cash payment upon FDA approval of Abraxane for pancreatic cancer by April 1, 2013



That could realistically only happen with an early halt to the trial given they just announced full accrual with results projected in 2012H2.

The pancreatic trial is the secret weapon in mine and rkrw's SI charity portfolio. It remains to be seen if it will shoot us each in the foot (or somewhere worse) or (hopefully) finish off our competitors.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up